Health Care: Drugs

Emergent BioSolutions Inc (EBS: NYSE)

$26.27 -0.02 | -0.08%
12/02/16 - 04:02 PM ET
Company Profile
Price and Volume
Recent Price 26.29
52 Week High 41.91
52 Week Low 24.47
Avg. Daily Vol. (Mil) 0.46
Beta (3 year) 1.30
Share Related Items
Mkt Cap (Mil) 1,064.69
Shares Out (Mil) 40.50
Float (Mil) 31.91
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.90
Current Ratio 5.10
LT Debt/ Equity 0.37
Total Debt / Equity 0.37
Valuation Ratios
Price Earnings 26.30
Price/Sales 2.03
Price/Book 1.58
Price/Cash Flow 10.70
Per Share Data
Earnings 1.00
Sales 12.93
Book Value 16.61
Cash Flow 2.45
Business Summary
Emergent BioSolutions Inc is a specialty biopharmaceutical company It develops, manufactures, and delivers a portfolio of medical countermeasures for government agencies in the areas of biological and chemical threats and emerging infectious diseases.
General Information
400 Professional Drive
Suite 400
Gaithersburg, MD 20879
www.emergentbiosolutions.com
Industry : Drugs
Sector: Health Care
Employees: 1292
CEO: Daniel J. Abdun-Nabi
Short Interest
Current Month (Mil) 4.56
Previous Month (Mil) 4.18
Short Interest Ratio (Days) 10.80
Management Effectiveness
Return on Equity 9.40
Return on Assets 6.00
Return on Investments 6.90
Profitability
Gross Margin 80.50
EBIT Margin 18.10
Profit Margin 9.10

Portfolios with EBS

Latest EBS Headlines from TheStreet

More Financial News for EBS

Press Releases for EBS

See All Press Releases

Partner Headlines for EBS

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter